Comments
Loading...
Harrow (NASDAQ:HROW) Stock Quotes, Forecast and News Summary
Harrow Stock (NASDAQ: HROW) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Harrow (HROW) stock?
You can purchase shares of Harrow (NASDAQ:HROW) through any online brokerage.
Who are Harrow (HROW) competitors?
Other companies in Harrow’s space includes: Supernus Pharmaceuticals (NASDAQ:SUPN), WAVE Life Sciences (NASDAQ:WVE), Tarsus Pharmaceuticals (NASDAQ:TARS), Phibro Animal Health (NASDAQ:PAHC) and Rapport Therapeutics (NASDAQ:RAPP).
What is the forecast, or price target, for Harrow (HROW) stock?
Harrow has a consensus price target of $44.33.
What is the current price for Harrow (HROW)?
The stock price for Harrow (NASDAQ: HROW) is $35.2132 last updated December 18, 2024 at 1:22 PM EST.
Does Harrow (HROW) pay a dividend?
There are no upcoming dividends for Harrow.
When is Harrow (NASDAQ:HROW) reporting earnings?
Harrow’s Q4 earnings are confirmed for Tuesday, March 18, 2025.
Is Harrow (HROW) going to split?
There is no upcoming split for Harrow.
What sector and industry does Harrow (HROW) operate in?
Harrow is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.